- Filed
- Jul 16, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Jun 28, 2024 | 5.78B sh |
| Shares Diluted restated | FY 2024 · Mar 31, 2023 | 8.31B sh |
| Operating Cash Flow | FY 2024 · Mar 31, 2023 | −$180.81K |
| Cash And Equivalents | FY 2024 · Mar 31, 2023 | $4.91K |
| Current Liabilities | FY 2024 · Mar 31, 2023 | $2.72M |
| Total Liabilities | FY 2024 · Mar 31, 2023 | $2.72M |
| Current Assets | FY 2024 · Mar 31, 2023 | $541.46K |
| Total Assets | FY 2024 · Mar 31, 2023 | $1.09M |
| Eps Diluted | FY 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | FY 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | FY 2024 · Mar 31, 2023 | $529.58K |
| Rd Expense | FY 2024 · Mar 31, 2023 | $259.5K |
| Net Income | FY 2024 · Mar 31, 2023 | −$1.32M |
| Operating Income | FY 2024 · Mar 31, 2023 | −$1.02M |
| Gross Profit | FY 2024 · Mar 31, 2023 | $128.54K |
| Cost Of Revenue | FY 2024 · Mar 31, 2023 | $70.28K |
| Revenue | FY 2024 · Mar 31, 2023 | $198.82K |
| Stockholders Equity | FY 2024 · Mar 31, 2022 | −$1.73M |